BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25664056)

  • 1. Association of serum chemerin levels with the severity of coronary artery disease in patients with metabolic syndrome.
    Aksan G; İnci S; Nar G; Soylu K; Gedikli Ö; Yüksel S; Özdemir M; Nar R; Meriç M; Şahin M
    Int J Clin Exp Med; 2014; 7(12):5461-8. PubMed ID: 25664056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome.
    Dong B; Ji W; Zhang Y
    Intern Med; 2011; 50(10):1093-7. PubMed ID: 21576834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of serum chemerin level with risk of coronary artery disease in Chinese adults.
    Yan Q; Zhang Y; Hong J; Gu W; Dai M; Shi J; Zhai Y; Wang W; Li X; Ning G
    Endocrine; 2012 Apr; 41(2):281-8. PubMed ID: 22042485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum chemerin levels are associated with the presence and extent of coronary artery disease.
    Xiaotao L; Xiaoxia Z; Yue X; Liye W
    Coron Artery Dis; 2012 Sep; 23(6):412-6. PubMed ID: 22828724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease.
    Wu Z; Cui H; Li W; Zhang Y; Liu L; Liu Z; Zhang W; Zheng T; Yang J
    Front Cardiovasc Med; 2022; 9():918359. PubMed ID: 35966520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome.
    Li B; Zhang LH; Yang XG; Liu XT; Ren YG
    Clin Invest Med; 2010 Dec; 33(6):E398-404. PubMed ID: 21134342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?
    Aksan G; Gedikli Ö; Keskin K; Nar G; İnci S; Yıldız SS; Kaplan Ö; Soylu K; Kılıçkesmez KO; Şahin M
    J Investig Med; 2016 Mar; 64(3):764-70. PubMed ID: 26912009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Adiponectin Resistance on Coronary Artery Disease Severity.
    Stojanovic S; Ilic MD; Ilic S; Saric S; Stojanovic S; Petrovic V
    Niger J Clin Pract; 2021 Aug; 24(8):1240-1246. PubMed ID: 34397037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between metabolic syndrome and angiographic severity of coronary artery disease.
    Miri R; Sajjadieh A; Parsamahjoob M; Hajibaratali B; Shekarchizadeh M; Kolahi AA; Sadeghi M; Ahmadi Z; Farmanara H; Shekarchizadeh-Esfahani M
    ARYA Atheroscler; 2016 Sep; 12(5):220-225. PubMed ID: 28458696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 11. High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization.
    Leiherer A; Muendlein A; Kinz E; Vonbank A; Rein P; Fraunberger P; Malin C; Saely CH; Drexel H
    Vascul Pharmacol; 2016 Feb; 77():60-8. PubMed ID: 26304698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes.
    Lin X; Tang X; Jiang Q; Liu Q; Lin Z; Lin J; Chen L; Hong H
    Clin Lab; 2012; 58(5-6):539-44. PubMed ID: 22783586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
    Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol.
    Su CS; Chen KJ; Sheu WH; Yang YL; Liu TJ; Chang WC; Wang KY; Lee WL
    Acta Cardiol Sin; 2015 Nov; 31(6):528-35. PubMed ID: 27122918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of wrist circumference for predicting the presence of coronary artery disease and metabolic syndrome.
    Hajsadeghi S; Firouzi A; Bahadoran P; Hassanzadeh M
    Indian Heart J; 2016 Dec; 68 Suppl 3(Suppl 3):S5-S9. PubMed ID: 28038723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome.
    Szpakowicz A; Szpakowicz M; Lapinska M; Paniczko M; Lawicki S; Raczkowski A; Kondraciuk M; Sawicka E; Chlabicz M; Kozuch M; Poludniewski M; Dobrzycki S; Kowalska I; Kaminski K
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease.
    Kim JY; Mun HS; Lee BK; Yoon SB; Choi EY; Min PK; Yoon YW; Hong BK; Rim SJ; Kwon HM
    Yonsei Med J; 2010 Sep; 51(5):676-82. PubMed ID: 20635441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome.
    Akçay AB; Camsarı A; Ozcan T; Ciçek D; Akkuş N; Seyis S; Cimen B; Celebi B; Döven O; Cin G
    Turk Kardiyol Dern Ars; 2011 Jul; 39(5):371-7. PubMed ID: 21743260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease.
    Nardin M; Verdoia M; Barbieri L; De Luca G;
    Platelets; 2019; 30(5):615-623. PubMed ID: 30047817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.